Norges Bank
RVMD icon

Norges Bank’s Revolution Medicines RVMD Stock Holding History

Norges Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,455,347
Closed -$196M – 1131
2025
Q4 		$196M Buy
+2,455,347
New +$161M 0.02% 525
2025
Q3 		– Sell
-1,701,111
Closed -$62.6M – 1254
2025
Q2 		$62.6M Buy
1,701,111
+297,583
+21% +$11.4M 0.01% 861
2025
Q1 		$49.6M Sell
1,403,528
-338,511
-19% -$13.7M 0.01% 941
2024
Q4 		$76.2M Sell
1,742,039
-4,562
-0.3% -$230K 0.01% 789
2024
Q3 		$79.2M Sell
1,746,601
-102,046
-6% -$4.44M 0.01% 771
2024
Q2 		$71.7M Buy
1,848,647
+140,371
+8% +$5.25M 0.01% 761
2024
Q1 		$55.1M Buy
1,708,276
+1,426,571
+506% +$42.3M 0.01% 894
2023
Q4 		$8.08M Sell
281,705
-157,982
-36% -$3.8M ﹤0.01% 1561
2023
Q3 		$12.2M Buy
439,687
+72,200
+20% +$2.14M ﹤0.01% 1392
2023
Q2 		$9.83M Sell
367,487
-146,529
-29% -$3.6M ﹤0.01% 1539
2023
Q1 		$11.1M Sell
514,016
-108,625
-17% -$2.67M ﹤0.01% 1540
2022
Q4 		$14.8M Buy
622,641
+67,900
+12% +$1.44M ﹤0.01% 1406
2022
Q3 		$10.9M Buy
554,741
+62,734
+13% +$1.38M ﹤0.01% 1501
2022
Q2 		$9.59M Buy
492,007
+19,456
+4% +$379K ﹤0.01% 1571
2022
Q1 		$12.1M Buy
472,551
+13,508
+3% +$294K ﹤0.01% 1630
2021
Q4 		$11.6M Buy
459,043
+53,077
+13% +$1.5M ﹤0.01% 1712
2021
Q3 		$11.2M Buy
405,966
+319,400
+369% +$9.3M ﹤0.01% 1729
2021
Q2 		$2.75M Sell
86,566
-82,168
-49% -$2.87M ﹤0.01% 1973
2021
Q1 		$7.74M Buy
+168,734
New +$7.57M ﹤0.01% 1846
2020
Q3 		– Sell
-48,245
Closed -$1.52M – 2159
2020
Q2 		$1.52M Sell
48,245
-21,755
-31% -$684K ﹤0.01% 1987
2020
Q1 		$1.53M Buy
+70,000
New +$1.94M ﹤0.01% 1949

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank's RVMD Position: Q1 2026 in Review

Norges Bank sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 2,455,347 shares — an estimated $196M sold.

Norges Bank first reported a position in RVMD in Q1 2020 and held it in 21 quarters. The position peaked at $196M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Norges Bank reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 2,455,347 Revolution Medicines shares in Q1 2026, an estimated $196M.
  • Norges Bank first reported a position in Revolution Medicines in Q1 2020 and held it in 21 quarters.
  • Norges Bank's Revolution Medicines position peaked at $196M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.